Iowa Neurological Association Annual Meeting

| Registration |
|---|
If you have questions, please email Grace Fleming. |
Description
The purpose of this activity is to increase the knowledge of learners in trends of medicine and disease factors related to neurology. The mission of the activity is to enhance the knowledge and skills of neurology practitioners in Iowa to serve their communities better.
Agenda
| Time | Presentation Title and Speaker | |
|---|---|---|
| 7:30 am | Registration and Breakfast | |
| 8:30 am | Updates in the Management of Concussion Erik Beltran, MD, ABPN
| |
| 9:30 am | Break | |
| 9:45 am | Chronic Inflammatory Demyelinating Polyneuropathy: Pathophysiology, Diagnosis, and New and Emerging Treatment Options Sudhir S. Athni, MD, MBA, ABPN
| Phenomenology of Common Movement Disorders Todd Ajax, MD, ABEM, ABPN, RPNI
|
| 10:45 am | Break | |
| 11:00 am | Treating Alzheimer's Disease in the Era of Anti-Amyloid Therapies HyungSub Shim, MD, ABPN
| Stroke Management Shivakrishna Kovi, MD, FAHA
|
| 12:00 pm | Lunch | |
| 1:15 pm | Neurogenetics Michael Shy, MD, ABPN Tiffany Grider, MS, LGC
| |
| 2:15 pm | Break | |
| 2:30 pm | Moving Makes Me Hot, or Heat Makes Me Move? Three-Year-Old With "Febrile" Ataxia Veronica Ramirez-Altamirano, MD
| |
| 3:00 pm | Adjourn | |
ACCREDITATION STATEMENTS
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and the Iowa Chapter American Academy of Pediatrics. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 4.50 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other healthcare providers: This activity is designated for 4.50 AMA PRA Category 1 Credit(s)™.
![]() | ![]() |
EDUCATIONAL GRANTS
No ineligible company provided financial support for this continuing education activity.
DISCLOSURES
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Erik Beltran, MD, ABPN - Speaker
- Grace Fleming, CNP - Activity Director
- Tiffany Grider, MS, LGC - Speaker
- Christopher Groth, MD, ABPN - Planning Committee Member
- Alex Hanson, MD - Planning Committee Member
- Rahul Khanna, MD, FAANEM, ABPN, ABEM - Planning Committee Member
- Shivakrishna Kovi, MD, FAHA, ABPN - Planning Committee Member and Speaker
- HyungSub Shim, MD, ABPN - Speaker
- John Wright, MD - Planning Committee Member
Relevant to the content of this educational activity, the following individual(s) do not have a financial relationship with an ineligible company; however, they intend to discuss the off-label use of a commercial product or device and agree to inform learners. All relevant financial relationships have been mitigated.
- Todd Ajax, MD, ABEM, ABPN, RPNI - Planning Committee Member and Speaker
- Veronica Ramirez-Altamirano, MD - Speaker
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated either through peer review by individuals with no relevant financial relationships or attestation to adhere to evidence-based guidelines for clinical recommendations.
- Sudhir Athni, MD, MBA, ABPN - Speaker
- Speaker's Bureau: Argenx, ANI Pharmaceuticals, Pfizer, Biogen
- Christine Gill, MD, ABPN - Planning Committee Member
- Advisory Board: TG Therapeutics
- Michael E. Shy, MD, ABPN - Speaker
- Consultant: Novartis, Applied Therapeutics, ActioBiosciences, Augustine Surgical, Inc.
- Grant or Research Support: Novartis, Elpida, AInylam
DISCLAIMER
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 4.50 AMA PRA Category 1 Credits™
- 4.50 AOA Category 2A
- 4.50 CE Contact Hour(s)
Price
Cost
- INA Member: $50
- Non-INA Member: $200
- Advanced Practice Providers and Nurses: $25
- Students and Residents: $0
If you have questions, please email Grace Fleming.

Facebook
X
LinkedIn
Forward
